Profile picture

Doctor Paolo Tolomeo

University of Glasgow, Glasgow (United Kingdom of Great Britain & Northern Ireland)
Follow
Logo ESC

Contributor content

Relative and absolute benefit of dapagliflozin using different eGFR estimates: insights from DAPA-HF trial
Presentation
Relative and absolute benefit of dapagliflozin using different eGFR estimates: insights from DAPA-HF trial
Read more
Effect of guideline-recommended medical therapy according to blood urea nitrogen
Presentation
Effect of guideline-recommended medical therapy according to blood urea nitrogen
Read more
Effect of neprilysin inhibition on blood urea nitrogen creatinine ratio in HFrEF : comparison of the solvd and paradigm-hf trials
Presentation
Effect of neprilysin inhibition on blood urea nitrogen creatinine ratio in HFrEF : comparison of the solvd and paradigm-hf trials
Read more
Implications of the 2021 CKD-EPI cystatin C/creatinine eGFR equation for eligibility for therapy in HFrEF: Insights from PARADIGM-HF
Presentation
Implications of the 2021 CKD-EPI cystatin C/creatinine eGFR equation for eligibility for therapy in HFrEF: Insights from PARADIGM-HF
Read more
Left ventricular outflow indices and sacubitril/valsartan up-titration: role of stroke volume index
Presentation
Left ventricular outflow indices and sacubitril/valsartan up-titration: role of stroke volume index
Read more

ESC 365 is supported by

novartis Explore sponsored resources